8:00 a.m.
Continental Breakfast & Networking

8:30 a.m.
Chairperson's Address & Opening Of Day Two:
Embracing Social Media To Foster Open Conversations,
Quick Responses, And Two-Way Engagement

The pharma industry has often been accused of being a laggard when it comes to the adoption of new and emerging technologies, and social media is no exception. In spite of the challenges and long awaited pending FDA guidance, many pharma companies have found ways to authentically engage in social media.

• What paths are pharma companies taking to authentically engage in social media?
• From "social media advisory board", to leveraging social listening to influence engagement, or finding ways to "push" marketing into "pull" marketing – what’s working, what’s not?
• Integrating social into your corporate, marketing, and communications efforts – future trends and opportunities

Shwen Gwee, Chief Digital Officer
Chandler Chicco Companies
Conference Chairperson

9:10 a.m.

mHealth – A Proof Of Concept Story In Patient Recruitment
Welcome to the next patient recruitment frontier – mobile technology to recruit patients for clinical trials! How receptive are patients to mobile health technology? How can mHealth be incorporated into a patient recruitment campaigns today. Can mHealth positively transform clinical trial recruitment?

• Understand the basics of mobile reach
• Align the goals of mHealth with the mobile app business model
  
• Learn from a measurable case study in clinical trial recruitment applying these technologies

Joseph Kim, MBA, Clinical Operations Director
SHIRE

9:40 a.m.

Idea Exchange: Questions, Feedback, Collaboration

9:50 a.m.

Morning Refreshment & Networking Break

10:00 a.m.

Brainstorming Session: Cutting-Edge Marketing On A Shoestring – Can I Afford To 'Socialize'?

It you want to stay competitive, you can’t afford to sit back and listen any longer! The New technological drivers are forcing marketers across industry sectors to engage in more face-to-face instantaneous dialogue with potential and existing consumers in order to retain the competitive edge! Think you cannot afford to dive in head first? Let’s see what your peers think? What metrics are available to help quantify the success of social media? What do available measurement tools tell us about the relevance of social media?

Pharma companies are continuously working to leverage the impact of social media in the patient community to a positive and beneficial end. How can you walk the fine line between operating within the parameters of existing regulatory guidelines to achieve positive, measurable results?

• Leveraging the impact of social media on the patient community
• Effectively participating in the social arena within regulatory guidelines
• Creating a robust blueprint for success and for measuring results

Linda Hetcher, Director, Digital Strategy & Services
Novartis 

Kelly Beyer, Associate Director Digital Strategy & Services
Novartis

11:00 a.m.

Idea Exchange: Questions, Feedback, Collaboration

11:10 a.m.

What Pharma Needs to Know About Avoiding The Risk of Non-Compliance In Social Media Marketing

Pharma marketing professionals keen on adopting social media technologies and campaigns designed to engage potential customers are under continuous pressure to do this in tandem with a strategy adhering to corporate compliance. In the absence of clear FDA guidelines, best practices are ever-evolving as pharma takes advantage of the ability to learn from the successes and failures of their competitors and peers.

• How can you avoid non-compliance and working with regulators to avoid and defend against an FDA warning letter
• Fashioning the appropriate response to FDA for:
  - warning letters
  - untitled letters
• Assessing the scope of the activity that has come under scrutiny
  - looking at potential additional vulnerabilities
• Lessons in the pharmaceutical context that can assist in developing an internal process for future marketing materials

Chair:

Peter Pitts, President
Center for Medicine in the Public Interest & Former Associate Commissioner for External Relations, FDA

Manfred Fleschar, Former Associate Director - Regulatory Affairs Ad Promo/CMC
Astellas Pharma US, Inc.

Sonali P. Gunawardhana, Of Counsel, FDA Practice Group
Wiley Rein LLP

Preeti Pinto, Pharmaceutical Regulatory and Compliance Expert
Preeti Pinto and Associates

12:00 p.m.
Chairperson's Recap:
Key Takeaways And What To Do When You Get Back To The Office

We'll recap the highlights of the past two days and ask you to share key insights and next steps with the group.

12:15 p.m.
Close Of General Sessions

Complete your conference experience with
Post-Conference Workshop D!

Take the information you gained from the general sessions and focus on your individual needs and applications. You will leave this hands-on workshop inspired and ready to embark on your own social media journey.

1:00 p.m. to 3:30 p.m.
Engaging Patients And Physicians In mHealth Conversations

Please click here for more info!